Female Health Tech Market Report 2024-2034, Featuring Athena Feminine Technologies, Bloomlife, HeraMED, iSono Health, Minerva Surgical, NUVO, Prelude Fertility, Sera Prognostics, Univfy and TotoHealth
April 11, 2024 09:45 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Female Health Tech Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.World revenue for the Female Health Tech...
Medicines360 Appoints Erica Rogers to Board of Directors
April 10, 2024 06:00 ET
|
Medicines360
Medicines360, a global mission-driven women's health company, has appointed Erica Rogers to the Board of Directors.
Global Fertility Services Market Analysis Report 2024-2030: Focus on United States, Canada, Germany, United Kingdom, France, Italy, China, Japan, South Korea, India
April 10, 2024 05:38 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment Type, Channel, Services , By Region, By Country: Market...
Polycystic Ovarian Syndrome (PCOS) Competitive Landscape Report 2024: Out of 18 Drugs in the Pipeline for PCOS, Only 3 have Reached the Phase III Stage of Development
April 09, 2024 10:50 ET
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape" report has been added to ResearchAndMarkets.com's offering. This report presents a...
Ovarian Cancer Opportunity Assessment Report 2024: A Blockbuster Market that is Expected to Grow from $3.3 Billion in 2022 to $4.1 Billion in 2032 with ImmunoGen, AstraZeneca, Merck, & GSK Dominating
April 09, 2024 07:02 ET
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering.Ovarian Cancer is one of the most...
Female Sexual Dysfunction (FSD) Clinical Landscape Report 2024: Only 3 Out of 24 Drugs in the Pipeline are in the Phase III Stage of Development
April 05, 2024 04:34 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Female Sexual Dysfunction (FSD) - Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This report offers a...
Global Women's Health Market 10 Year Forecast Report 2024-2034 - Growing Shift Towards Preventive Healthcare
March 29, 2024 05:19 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Women's Health Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.The women's health market is experiencing a...
China Non-Invasive Prenatal Testing Market Research Report 2024-2032 Featuring Basetra, Berry Genomics, and BGI Diagnosis
March 29, 2024 05:17 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032)" report has been added to ResearchAndMarkets.com's...
Global PMS and Menstrual Health Supplements Market Analysis, 2024-2028 & 2033, by Product, Formulation, Consumer Group, Sales Channel, and Region
March 26, 2024 13:17 ET
|
Research and Markets
Dublin, March 26, 2024 (GLOBE NEWSWIRE) -- The "PMS and Menstrual Health Supplements Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The PMS and menstrual...
Global Myomectomy Market to Reach 2.08 Billion by 2034, Showcasing a 9.18% CAGR During 2024-2034
March 26, 2024 05:01 ET
|
Research and Markets
Dublin, March 26, 2024 (GLOBE NEWSWIRE) -- The "Global Myomectomy Market Analysis & Forecast to 2024-2034: Market By Type; By Product; By End-user; and By Region" report has been added to ...